Early in post-natal development heart muscle cell division is arrested and subsequent growth results from hypertrophic increases in cardiac myocyte size. Although hypertrophic growth ceases in the mature heart, many cardiac-related disorders, such as hypertension, provoke its reinitiation. This renewed growth is initially compensatory but eventually leads to a decompensatory reduction of cardiac muscle mass due to myocyte apoptosis, decreased cardiac function and, ultimately, to heart failure. Our long-term objective is to understand the signal transduction mechanisms that regulate cardiac growth and apoptosis. This proposal addresses the hypothesis that the p38 mitogen activated protein kinases (MAPK) play pivotal roles in determining the balance between cardiac myocyte growth and apoptosis, and that the relative activity states of p38 isoforms, e.g. p38alpha and p38beta, serves as a crucial determinant of myocyte fate. To address the mechanism by which p38 isoforms can be differentially activated in the heart, we propose the following Specific Aims: 1) To identify members of proposed p38 signaling complexes in cardiac myocytes. Using Western- and Northern analyses, as well as yeast two-hybrid screening, proteins in the heart that comprise complexes that direct signals toward growth or apoptosis, including hypothetical scaffold proteins, will be identified and, in the case of newly-discovered molecules, their structures and properties determined. 2) To characterize the cellular functions of p38 signaling complex members. Here, we will use a novel antisense oligonucleotide approach and overexpression of key signaling proteins to selectively perturb levels of signaling participants in cultured cardiac myocytes. Effects on the gene expression and morphological characteristics associated with cardiac hypertrophy and apoptosis will be assessed. 3) To elucidate the effects of manipulating the levels of p38 signaling complex members on heart structure and performance in vivo using cardiac-targeted transgenic mouse models. These studies employ novel combinations of powerful molecular approaches to unravel the roles of the recently-discovered p38 MAP kinases in cardiac myocyte growth. We anticipate that the results will provide new information that is required to move the field forward in the search for gene therapy targets aimed at solving problems related to the unusual hypertrohic growth program exhibited by cardiac myocytes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL063975-02
Application #
6351603
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Reinlib, Leslie
Project Start
2000-02-07
Project End
2004-01-31
Budget Start
2001-02-01
Budget End
2002-01-31
Support Year
2
Fiscal Year
2001
Total Cost
$332,784
Indirect Cost
Name
San Diego State University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
073371346
City
San Diego
State
CA
Country
United States
Zip Code
92182
Glembotski, Christopher C (2013) Classic studies of cultured cardiac myocyte hypertrophy: interview with a transformer. Circ Res 113:1112-6
Wall, Jason A; Wei, Jing; Ly, Mimi et al. (2006) Alterations in oxidative phosphorylation complex proteins in the hearts of transgenic mice that overexpress the p38 MAP kinase activator, MAP kinase kinase 6. Am J Physiol Heart Circ Physiol 291:H2462-72
Martindale, Joshua J; Fernandez, Rayne; Thuerauf, Donna et al. (2006) Endoplasmic reticulum stress gene induction and protection from ischemia/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6. Circ Res 98:1186-93
Martindale, Joshua J; Wall, Jason A; Martinez-Longoria, Diana M et al. (2005) Overexpression of mitogen-activated protein kinase kinase 6 in the heart improves functional recovery from ischemia in vitro and protects against myocardial infarction in vivo. J Biol Chem 280:669-76
Morrison, Lisa E; Whittaker, Ross J; Klepper, Robert E et al. (2004) Roles for alphaB-crystallin and HSPB2 in protecting the myocardium from ischemia-reperfusion-induced damage in a KO mouse model. Am J Physiol Heart Circ Physiol 286:H847-55
Andrews, Catherine; Ho, Peter D; Dillmann, Wolfgang H et al. (2003) The MKK6-p38 MAPK pathway prolongs the cardiac contractile calcium transient, downregulates SERCA2, and activates NF-AT. Cardiovasc Res 59:46-56
Degousee, Norbert; Martindale, Joshua; Stefanski, Eva et al. (2003) MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo. Circ Res 92:757-64
Morrison, Lisa E; Hoover, Holly E; Thuerauf, Donna J et al. (2003) Mimicking phosphorylation of alphaB-crystallin on serine-59 is necessary and sufficient to provide maximal protection of cardiac myocytes from apoptosis. Circ Res 92:203-11
O'Brien, Nicole W; Gellings, Nicole M; Guo, Mei et al. (2003) Factor associated with neutral sphingomyelinase activation and its role in cardiac cell death. Circ Res 92:589-91
Degousee, N; Stefanski, E; Lindsay, T F et al. (2001) p38 MAPK regulates group IIa phospholipase A2 expression in interleukin-1beta -stimulated rat neonatal cardiomyocytes. J Biol Chem 276:43842-9

Showing the most recent 10 out of 13 publications